Research Focus

Former Employee. Research and Technology Management; Manager, Protocol Activation Core

Recent additions – View all

1. A multicenter, first-in-pediatrics, phase 1, pharmacokinetic and pharmacodynamic study of ridaforolimus in patients with refractory solid tumors

   Journal Article

   Gore, L.; Trippett, T. M.; Katzenstein, H. M.; Boklan, J.; Narendran, A.; Smith, A.; Macy, M. E.; Rolla, K.; Narashimhan, N.; Squillace, R. M.; more...
   Clinical Cancer Research (2013)

   Fulltext@MSK | Save
2. A multi-center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors

   Journal Article

   Macy, M. E.; Duncan, T.; Whitlock, J.; Hunger, S. P.; Boklan, J.; Narendren, A.; Herzog, C.; Arceci, R. J.; Bagatell, R.; Trippett, T.; more...
   Pediatric Blood and Cancer (2013)

   Fulltext@MSK | Save
3. Phase I dose-escalation trial of clofarabine followed by escalating doses of fractionated cyclophosphamide in children with relapsed or refractory acute leukemias

   Journal Article

   Abd Elmoneim, A.; Gore, L.; Ricklis, R. M.; Boklan, J.; Cooper, T.; Narendran, A.; Rolla, K.; Scott, T.; Arceci, R. J.
   Pediatric Blood and Cancer (2012)

   Fulltext@MSK | Save